2022
DOI: 10.1007/s42770-022-00737-x
|View full text |Cite
|
Sign up to set email alerts
|

Trichosporon asahii causing subcutaneous mycoses in an immunocompetent patient: case report and a minireview

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 52 publications
0
2
0
Order By: Relevance
“…Trichosporon spp. is known to be a commensal organism of the digestive tract and can colonize the skin of healthy patients [8]. Although it is usually associated with infections in immunocompromised patients, there are reported cases of infections in immunocompetent individuals, especially after surgical interventions, as seen in our patient.…”
Section: Discussionmentioning
confidence: 68%
See 1 more Smart Citation
“…Trichosporon spp. is known to be a commensal organism of the digestive tract and can colonize the skin of healthy patients [8]. Although it is usually associated with infections in immunocompromised patients, there are reported cases of infections in immunocompetent individuals, especially after surgical interventions, as seen in our patient.…”
Section: Discussionmentioning
confidence: 68%
“…Unfortunately, the treatment of trichosporonosis remains a challenge because few studies have been dedicated to evaluating the in vitro and in vivo activities of different antifungals against clinically relevant Trichosporon species [4]. Nevertheless, the literature indicates that azoles, except for fluconazole, have good activities against Trichosporon species, while amphotericin B shows limited in vitro and in vivo activity against these microorganisms [8]. Our patient improved significantly under voriconazole, which has demonstrated superior in vitro activities against Trichosporon species compared to amphotericin B or fluconazole [14][15][16].…”
Section: Discussionmentioning
confidence: 99%